Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TERPMED

Financiado

Cerrado

Plant Terpenoids for Human Health a chemical and genomic approach to identify a...

Plant Terpenoids for Human Health a chemical and genomic approach to identify and produce bioactive compounds Plant secondary metabolites are an important source of therapeutic drugs or drug leads. The advent of genomic and metabolomic technologies has now made it possible to bring the field of plant natural products into the 21st century... ver más

31/05/2013

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSIDAD DE BARCELONA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 324

Fecha límite participación Sin fecha límite de participación.

Ver 9 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-05-31 No tenemos la información de la convocatoria

0% 73% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

9 Participantes

0.00€ | Lider

IBISS

N.D. | Participante

ARISTOTLE UNIVERSITY OF THES...

N.D. | Participante

THE BOARD OF REGENTS OF THE...

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSIDAD DE BARCELONA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 324

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Plant secondary metabolites are an important source of therapeutic drugs or drug leads. The advent of genomic and metabolomic technologies has now made it possible to bring the field of plant natural products into the 21st century and replace serendipitous and haphazard finding by rational design and discovery. This proposal is devoted to plant terpenes, the largest and most diverse group of plant natural products. TERPMED will focus on sesquiterpene lactones and phenolic diterpenes because of the presence of distinct functional groups and their high potential as novel human drugs for treating cancer and neurological disorders. By using a combination of comparative metabolomics and genomics, significant advances will be achieved in the understanding of the biosynthetic pathways of these compounds. Focusing on specific functional groups such as γ-butyrolactones and phenolics amongst the terpenes will allow the development of high-throughput analytical methodologies to detect, purify and characterize compounds bearing these groups. A comprehensive library of these compounds within a subset of plant biodiversity will be established. The compounds isolated will be tested for biological activity and the most active molecules will be selected. High throughput cDNA sequencing coupled to the comparative analysis of the metabolic profiles of targeted species will be achieved for the elucidation of the biosynthetic pathways of these compounds. Innovative production platforms using plant secretory organs such as the trichomes will be tested for the pilot production of the most promising compounds identified and the production of novel compounds by combinatorial biosynthesis.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores